Updated September 2026A hundred off, onceThe Edit review
The first figure is a hundred dollars off the standing rate, applied automatically and only once.
The verdict
The Edit publishes $209 a month for compounded semaglutide, read August 2026, with a first order at $109 via an automatic $100-off promotion. Tirzepatide is $309 after a $209 first order. Fifty states are covered.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- States
- 50
- From
- $209/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states
The Edit sells both molecules by injection across fifty states, with prepay tiers billed once upfront and a first-order discount applied without a code.
Who writes the prescription, and what do they see?
A prescription precedes shipping. The pages state rates and tiers. The clinician is not described and the intake is not documented.
An automatically applied discount is better than a code a reader has to find. It has the same consequence: the figure a buyer meets first is not the one they will pay. The standing rate is published beside it, which is the part that matters.
What happens when the dose goes up?
Both lines are stated flat, so the rate holds as the dose rises. The prepay tiers are about term rather than dose, so neither variable is left unstated.
What the price includes
Six months of semaglutide is $1,154 counting the discounted first order. Prepaying instead brings it to $575 for three months, about $192 a month, or $1,065 for six, about $178. Tirzepatide runs $209 for a first order then $309. Budgeting from $109 would give $654 over six months, roughly $500 short.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: The discount applies without a code
- Strength: Standing rates published beside it
- Strength: Prepay totals stated, not just rates
- Strength: Coverage across all fifty states
- Limitation: The first figure is a one-time discount
- Limitation: Six months costs about $500 more than it implies
- Limitation: Prepaid tiers bill in one charge
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about The Edit. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who reads the standing rate beside the first-order figure.
- Wrong for
- A reader budgeting six months from $109.
How The Edit compares
| Seller | Who it suits | Go |
|---|---|---|
 TMates | Readers choosing between formats who do not want the choice priced | See TMates → |
 TeleClinic | Readers who want tirzepatide without the usual premium over semaglutide | See TeleClinic → |
 Telos Rx | Readers taking the longest plan, since no shorter term carries a published rate | See Telos Rx → |
More GLP-1 telehealth sellers reviews: LongevixxLttlLuma MedsLumoraLuvo HealthLVNG RX
Sponsored alternative
Synergy Rx
A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.
Check Synergy Rx availability →Frequently asked
- Is $109 the ongoing price?
- No. It is a first order with $100 applied automatically. The standing rate is $209 a month.
- What do the prepay tiers cost?
- $575 for three months and $1,065 for six, billed once upfront, which is about $192 and $178 a month.
- Does the price rise with the dose?
- No. Both lines are stated flat across doses.
- Is The Edit legit?
- The Edit is a GLP-1 telehealth sellers service. Its stated availability: All 50 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is The Edit expensive compared with other GLP-1 telehealth sellers?
- The Edit publishes a starting figure of $209/mo. Across the 149 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts The Edit above the median. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.